Literature DB >> 3127803

Bilirubin decreases phosphorylation of synapsin I, a synaptic vesicle-associated neuronal phosphoprotein, in intact synaptosomes from rat cerebral cortex.

T W Hansen1, D Bratlid, S I Walaas.   

Abstract

The mechanisms by which bilirubin causes neurotoxicity in newborns have not been well defined, but an involvement in synaptic transmission appears possible. Herein we present evidence for an inhibitory effect of bilirubin on both basal and depolarization-induced (50 mM KCl) phosphorylation of synapsin I, a synaptic vesicle-associated protein that may play a role in neurotransmitter release. Synaptosomes from rat cerebral cortices, prelabeled with 32P in vitro to label the intraterminal ATP pool, were incubated with or without bilirubin and bovine serum albumin (added as a stabilizer) at varying doses and for different time intervals. Some preparations were also depolarized by high KCl concentrations to induce Ca++ influx. The phosphorylation of synapsin I was monitored. Our results show that addition of bilirubin to the medium significantly decreases 32P incorporation into synapsin I, both under basal and depolarizing conditions, in a time- and dose-dependent manner, significant effects being observed already at 10 microM bilirubin after 120-min incubation of the synaptosomes. Separate analysis of the multiple phosphorylation sites in synapsin I showed that the phosphorylation of both the "head" and "tail" regions of the protein was decreased by bilirubin. Removal of the bilirubin-containing incubation medium retarded the decrease in synapsin I 32P content, indicating that the effect observed may be reversible. The nontoxic pyrrole biliverdin had no effect on synapsin I phosphorylation under the experimental conditions used, indicating that the effect was specific to bilirubin. Our results thus suggest that bilirubin may achieve some of its reversible effects on the brain through inhibition of the phosphorylation of the synapsic vesicle-associated protein synapsin I.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3127803     DOI: 10.1203/00006450-198802000-00018

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

1.  Changes in BAER wave amplitudes in relation to total serum bilirubin level in term neonates.

Authors:  Ze Dong Jiang; Dorothea Mary Brosi; Andrew Robert Wilkinson
Journal:  Eur J Pediatr       Date:  2009-01-08       Impact factor: 3.183

2.  Changes in the expression of synapsin I and II messenger RNA during postnatal rat brain development.

Authors:  U Zurmöhle; J Herms; R Schlingensiepen; W Brysch; K H Schlingensiepen
Journal:  Exp Brain Res       Date:  1996-03       Impact factor: 1.972

3.  Bilirubin inhibits Ca2+-dependent release of norepinephrine from permeabilized nerve terminals.

Authors:  T W Hansen; S B Mathiesen; I Sefland; S I Walaas
Journal:  Neurochem Res       Date:  1999-06       Impact factor: 3.996

4.  Endocytosis in rat cultured astrocytes is inhibited by unconjugated bilirubin.

Authors:  R F Silva; L M Mata; S Gulbenkian; D Brites
Journal:  Neurochem Res       Date:  2001-07       Impact factor: 3.996

5.  Interactions of bilirubin with isolated presynaptic nerve terminals: functional effects on the uptake and release of neurotransmitters.

Authors:  E L Ochoa; R P Wennberg; Y An; T Tandon; T Takashima; T Nguyen; A Chui
Journal:  Cell Mol Neurobiol       Date:  1993-02       Impact factor: 5.046

6.  Changes of synapsin I messenger RNA expression during rat brain development.

Authors:  U M Zurmöhle; J Herms; R Schlingensiepen; K H Schlingensiepen; W Brysch
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

7.  Bilirubin modulates acetylcholine receptors in rat superior cervical ganglionic neurons in a bidirectional manner.

Authors:  Chengmi Zhang; Zhenmeng Wang; Jing Dong; Ruirui Pan; Haibo Qiu; Jinmin Zhang; Peng Zhang; Jijian Zheng; Weifeng Yu
Journal:  Sci Rep       Date:  2014-12-15       Impact factor: 4.379

8.  Evaluation of region selective bilirubin-induced brain damage as a basis for a pharmacological treatment.

Authors:  Matteo Dal Ben; Cristina Bottin; Fabrizio Zanconati; Claudio Tiribelli; Silvia Gazzin
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

9.  Predictive value of different bilirubin subtypes for clinical outcomes in patients with acute ischemic stroke receiving thrombolysis therapy.

Authors:  Qiwei Peng; Rentang Bi; Shengcai Chen; Jiefang Chen; Zhifang Li; Jianzhuang Li; Huijuan Jin; Bo Hu
Journal:  CNS Neurosci Ther       Date:  2021-11-14       Impact factor: 5.243

10.  Unconjugated bilirubin exposure impairs hippocampal long-term synaptic plasticity.

Authors:  Fang-Yu Chang; Cheng-Che Lee; Chiung-Chun Huang; Kuei-Sen Hsu
Journal:  PLoS One       Date:  2009-06-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.